Mackenzie Financial Corp Has $573,000 Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Mackenzie Financial Corp raised its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 11.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,278 shares of the company’s stock after buying an additional 1,365 shares during the period. Mackenzie Financial Corp’s holdings in Bath & Body Works were worth $573,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Shell Asset Management Co. increased its stake in shares of Bath & Body Works by 180.0% in the third quarter. Shell Asset Management Co. now owns 56,344 shares of the company’s stock valued at $1,904,000 after buying an additional 36,222 shares during the period. Pearl River Capital LLC grew its holdings in Bath & Body Works by 145.6% during the 3rd quarter. Pearl River Capital LLC now owns 31,364 shares of the company’s stock worth $1,060,000 after acquiring an additional 18,596 shares during the last quarter. Impax Asset Management Group plc increased its position in Bath & Body Works by 305.6% in the 4th quarter. Impax Asset Management Group plc now owns 356,910 shares of the company’s stock valued at $15,404,000 after acquiring an additional 268,913 shares during the period. Aigen Investment Management LP bought a new position in shares of Bath & Body Works during the third quarter valued at $1,697,000. Finally, Vanguard Group Inc. raised its stake in shares of Bath & Body Works by 0.3% during the third quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company’s stock valued at $868,307,000 after acquiring an additional 67,920 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

BBWI has been the subject of a number of recent research reports. Telsey Advisory Group restated an “outperform” rating and issued a $53.00 price objective on shares of Bath & Body Works in a report on Friday, April 5th. Wells Fargo & Company increased their price target on Bath & Body Works from $42.00 to $48.00 and gave the company an “equal weight” rating in a research note on Wednesday. Evercore ISI lifted their price objective on Bath & Body Works from $30.00 to $45.00 and gave the stock an “in-line” rating in a research note on Friday, March 1st. UBS Group increased their target price on shares of Bath & Body Works from $46.00 to $52.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. Finally, The Goldman Sachs Group boosted their price target on shares of Bath & Body Works from $49.00 to $56.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $46.73.

Insider Buying and Selling

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of Bath & Body Works stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.19% of the stock is currently owned by company insiders.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $46.03 on Friday. Bath & Body Works, Inc. has a one year low of $27.30 and a one year high of $50.34. The business has a 50-day simple moving average of $46.22 and a 200 day simple moving average of $40.54. The firm has a market capitalization of $10.35 billion, a price-to-earnings ratio of 11.96, a PEG ratio of 1.48 and a beta of 1.86.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.21. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The company had revenue of $2.91 billion for the quarter, compared to analysts’ expectations of $2.84 billion. During the same period last year, the business earned $1.86 EPS. Bath & Body Works’s quarterly revenue was up .8% compared to the same quarter last year. On average, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 1.74%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works’s payout ratio is presently 20.78%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.